<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="correction" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Oncol.</journal-id>
<journal-title>Frontiers in Oncology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Oncol.</abbrev-journal-title>
<issn pub-type="epub">2234-943X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fonc.2022.1072594</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Oncology</subject>
<subj-group>
<subject>Correction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Corrigendum: The incidence risk of breast and gynecological cancer by antidepressant use: A systematic review and dose&#x2013;response meta-analysis of epidemiological studies involving 160,727 patients</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhuang</surname><given-names>Yanjia</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1804300"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pang</surname><given-names>Xiaogang</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qi</surname><given-names>Yuchen</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname><given-names>Tianshu</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cao</surname><given-names>Guimao</given-names>
</name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xue</surname><given-names>Heming</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname><given-names>Yifan</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xie</surname><given-names>Shuoxin</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname><given-names>Yifan</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname><given-names>Yinuo</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1807393"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname><given-names>Yunxiao</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiong</surname><given-names>Ying</given-names>
</name>
<xref ref-type="aff" rid="aff7"><sup>7</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Li</surname><given-names>Yuanyuan</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/445434"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Shen</surname><given-names>Hui</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1805465"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Laboratory of Brain Science, Innovation Research Institute of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine</institution>, <addr-line>Jinan</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Experimental Center, Shandong University of Traditional Chinese Medicine</institution>, <addr-line>Jinan</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>School of health, Shandong University of Traditional Chinese Medicine</institution>, <addr-line>Jinan</addr-line>, <country>China</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Anesthesiology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine</institution>, <addr-line>Jinan</addr-line>, <country>China</country></aff>
<aff id="aff5"><sup>5</sup><institution>School of Medicine, Shandong University of Traditional Chinese Medicine</institution>, <addr-line>Jinan</addr-line>, <country>China</country></aff>
<aff id="aff6"><sup>6</sup><institution>School of Acupuncture, Shandong University of Traditional Chinese Medicine</institution>, <addr-line>Jinan</addr-line>, <country>China</country></aff>
<aff id="aff7"><sup>7</sup><institution>Innovation Research Institute of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine</institution>, <addr-line>Jinan</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Approved by: Frontiers  Editorial Office, Frontiers Media SA, Switzerland</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Hui Shen, <email xlink:href="mailto:huishenlj@hotmail.com">huishenlj@hotmail.com</email>; Yuanyuan Li, <email xlink:href="mailto:lyy05_2012@163.com">lyy05_2012@163.com</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Cancer Epidemiology and Prevention, a section of the journal Frontiers in Oncology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>08</day>
<month>11</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>12</volume>
<elocation-id>1072594</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>10</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>10</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Zhuang, Pang, Qi, Zhang, Cao, Xue, Xu, Xie, Liu, Wang, Li, Xiong, Li and Shen</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Zhuang, Pang, Qi, Zhang, Cao, Xue, Xu, Xie, Liu, Wang, Li, Xiong, Li and Shen</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" xlink:href="10.3389/fonc.2022.939636" ext-link-type="doi">A Corrigendum on <article-title>The incidence risk of breast and gynecological cancer by antidepressant use: A systematic review and dose&#x2013;response meta-analysis of epidemiological studies involving 160,727 patients</article-title> by Zhuang Y, Pang X, Qi Y, Zhang T, Cao G, Xue H, Xu Y, Xie S, Liu Y, Wang Y, Li Y, Xiong Y, Li Y and Shen H (2022). Front. Oncol. 12:939636. doi:&#xa0;<object-id>10.3389/fonc.2022.939636</object-id>
</related-article>
<kwd-group>
<kwd>antidepressant</kwd>
<kwd>depression</kwd>
<kwd>breast cancer</kwd>
<kwd>gynecological cancer</kwd>
<kwd>Incidence</kwd>
<kwd>meta-analysis</kwd>
<kwd>systematic review</kwd>
<kwd>dose-response analysis</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="3"/>
<word-count count="311"/>
</counts>
</article-meta>
</front>
<body>
<p>In the published article, there were three instances where there was a mistake in the cited references. This is because the references were renumbered sequentially after revision of manuscript.</p>
<p>In the Results section, the sentence &#x201c;By comparison, a non-linear dose&#x2013;response meta-analysis with 13 eligible studies (37-39, 42, 48, 55-57, 60, 61, 66, 83, 84)&#x201d; has been changed to &#x201c;By comparison, a non-linear dose&#x2013;response meta-analysis with 13 eligible studies (37, 38, 42, 47, 48, 55-57, 60, 61, 66, 83, 84)&#x201d;.</p>
<p>In the Results section, the sentence &#x201c;Another negative linearity association also existed between the CDDD and the incidence risk of endometrial, corpus uteri, and cervical cancer, from four eligible studies (30, 33, 34, 72)&#x201d; has been changed to &#x201c;Another negative linearity association also existed between the CDDD and the incidence risk of endometrial, corpus uteri, and cervical cancer, from four eligible studies (28, 45, 49, 86)&#x201d;.</p>
<p>In the Discussion section, the sentence &#x201c;Moreover, different from several studies that have found that prolactin may encourage the development of estrogen receptor (ER)-positive tumors (89) and higher risk in in situ (51, 85)&#x201d; has been changed to &#x201c;Moreover, different from several studies that have found that prolactin may encourage the development of estrogen receptor (ER)-positive tumors (89) and higher risk in in situ (52, 85)&#x201d;.</p>
<p>The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.</p>
<sec id="s1" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
</article>